Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Two years of Truvada for pre-exposure prophylaxis utilization in the US.

Flash C, Landovitz R, Giler RM, Ng L, Magnuson D, Wooley SB, Rawlings K.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19730. doi: 10.7448/IAS.17.4.19730. eCollection 2014.

PMID:
25397476
[PubMed - in process]
Free PMC Article
2.

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS; ACTG A5257 Team.

Ann Intern Med. 2014 Oct 7;161(7):I-22. doi: 10.7326/P14-9035. No abstract available.

PMID:
25285557
[PubMed - in process]
3.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS; ACTG A5257 Team.

Ann Intern Med. 2014 Oct 7;161(7):461-71. doi: 10.7326/M14-1084.

PMID:
25285539
[PubMed - in process]
4.

Moving HIV PrEP from research into practice.

Landovitz RJ, Coates TJ.

Lancet Infect Dis. 2014 Sep;14(9):781-3. doi: 10.1016/S1473-3099(14)70747-9. Epub 2014 Jul 22. No abstract available.

PMID:
25065858
[PubMed - indexed for MEDLINE]
5.

Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention.

Pines HA, Gorbach PM, Reback CJ, Landovitz RJ, Mutchler MG, Mitsuyasu R.

AIDS Care. 2014 Dec;26(12):1609-18. doi: 10.1080/09540121.2014.936821. Epub 2014 Jul 15.

PMID:
25022198
[PubMed - in process]
6.

Uptake and repeat use of postexposure prophylaxis in a community-based clinic in Los Angeles, California.

Beymer MR, Bolan RK, Flynn RP, Kerrone DR, Pieribone DL, Kulkarni SP, Stitt JC, Mejia E, Landovitz RJ.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):848-55. doi: 10.1089/AID.2014.0017. Epub 2014 Jul 29.

PMID:
24970113
[PubMed - in process]
7.
8.

Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery.

Pines HA, Gorbach PM, Weiss RE, Shoptaw S, Landovitz RJ, Javanbakht M, Ostrow DG, Stall RD, Plankey M.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):579-86. doi: 10.1097/QAI.0000000000000101.

PMID:
24378726
[PubMed - indexed for MEDLINE]
9.

Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies.

Etter P, Landovitz R, Sibeko S, Sobieszczyk ME, Riddler SA, Karg C, Tsibris A, Schouten J.

AIDS. 2013 Apr 24;27(7):1119-28. doi: 10.1097/QAD.0b013e32835dc08e. Review.

PMID:
23262497
[PubMed - indexed for MEDLINE]
10.

Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using GRINDR in Los Angeles, California.

Landovitz RJ, Tseng CH, Weissman M, Haymer M, Mendenhall B, Rogers K, Veniegas R, Gorbach PM, Reback CJ, Shoptaw S.

J Urban Health. 2013 Aug;90(4):729-39. doi: 10.1007/s11524-012-9766-7.

PMID:
22983721
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.

Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK; GS-US-236-0102 study team.

Lancet. 2012 Jun 30;379(9835):2439-48. doi: 10.1016/S0140-6736(12)60917-9. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

PMID:
22748591
[PubMed - indexed for MEDLINE]
12.

A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.

Landovitz RJ, Fletcher JB, Inzhakova G, Lake JE, Shoptaw S, Reback CJ.

AIDS Patient Care STDS. 2012 Jun;26(6):320-8. doi: 10.1089/apc.2011.0432.

PMID:
22680280
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study.

Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW.

AIDS Patient Care STDS. 2012 Feb;26(2):87-94. doi: 10.1089/apc.2011.0283. Epub 2011 Dec 7.

PMID:
22149764
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships.

Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee SJ, Leibowitz AA.

AIDS Care. 2011 Sep;23(9):1136-45. doi: 10.1080/09540121.2011.554528. Epub 2011 May 24.

PMID:
21476147
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Preexposure prophylaxis for HIV prevention.

Kelesidis T, Landovitz RJ.

Curr HIV/AIDS Rep. 2011 Jun;8(2):94-103. doi: 10.1007/s11904-011-0078-4. Review.

PMID:
21465112
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Aching for a diagnosis.

Afsarmanesh N, Nayeb-Hashemi H, Landovitz R.

J Hosp Med. 2010 Jan;5(1):55-9. doi: 10.1002/jhm.608. No abstract available.

PMID:
20063393
[PubMed - indexed for MEDLINE]
17.

Clinical practice. Postexposure prophylaxis for HIV infection.

Landovitz RJ, Currier JS.

N Engl J Med. 2009 Oct 29;361(18):1768-75. doi: 10.1056/NEJMcp0904189. Review. No abstract available.

PMID:
19864675
[PubMed - indexed for MEDLINE]
Free Article
18.

Occupational and nonoccupational postexposure prophylaxis for HIV in 2009.

Landovitz RJ.

Top HIV Med. 2009 Jul-Aug;17(3):104-8. Review. Erratum in: Top HIV Med. 2009 Sep-Oct;17(4):134.

PMID:
19675368
[PubMed - indexed for MEDLINE]
Free Article
19.

Availability of HIV postexposure prophylaxis services in Los Angeles County.

Landovitz RJ, Combs KB, Currier JS.

Clin Infect Dis. 2009 Jun 1;48(11):1624-7. doi: 10.1086/598976.

PMID:
19400685
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antiretroviral rounds. Immediate ART after an OI: are we there yet?

Grant P, Zolopa A, Landovitz RJ.

AIDS Clin Care. 2008 Sep;20(9):74-5. No abstract available.

PMID:
18841619
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk